Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-005211
Filing Date
2020-01-28
Accepted
2020-01-28 17:14:08
Documents
1
Period of Report
2020-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7509
  Complete submission text file 0001209191-20-005211.txt   8844
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UROGEN PHARMA LTD 9 HA'TA'ASIYA STREET RA'ANANA L3 4365007
Business Address
Mullennix Stephen (Reporting) CIK: 0001764139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38079 | Film No.: 20555526